
Sumitomo Pharma Co., Ltd.
4506 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区道修町2丁目6番8号
- Website:
- https://www.sumitomo-pharma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Sumitomo Pharma Co., Ltd. is a leading Japanese pharmaceutical company dedicated to improving global healthcare through innovative research and development. With a focus on oncology, psychiatry, and neurology, the company aspires to enhance its global presence by leveraging its robust R&D capabilities, skilled workforce, and diverse business platforms. By FY2033, Sumitomo Pharma aims to effectively transform its "value creation cycle," translating cutting-edge science into practical healthcare solutions. The company's commitment to sustainability and employee development fosters a dynamic corporate culture, promoting diversity and professional growth. With strategic operations in Japan and the U.S., Sumitomo Pharma is poised to meet the evolving needs of patients worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-27 09:05 |
Inside Information Statement
臨時報告書
|
Japanese | 29.6 KB | |
2025-06-26 09:39 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
2025-06-26 09:36 |
Internal Control over Financial Reporting
内部統制報告書-第205期(2024/04/01-2025/03/31)
|
Japanese | 24.0 KB | |
2025-06-26 09:31 |
Annual Report
有価証券報告書-第205期(2024/04/01-2025/03/31)
|
Japanese | 2.1 MB | |
2025-05-30 09:41 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 40.7 KB | |
2025-05-14 09:18 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 36.6 KB | |
2025-04-28 10:06 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 24.3 KB | |
2025-04-28 10:03 |
Inside Information Statement
臨時報告書
|
Japanese | 19.0 KB | |
2025-04-03 09:39 |
Inside Information Statement
臨時報告書
|
Japanese | 41.7 KB | |
2025-01-31 08:11 |
Inside Information Statement
臨時報告書
|
Japanese | 18.7 KB | |
2024-12-19 07:19 |
Inside Information Statement
臨時報告書
|
Japanese | 19.2 KB | |
2024-11-01 03:30 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
2024-11-01 03:26 |
Interim Report
半期報告書-第205期(2024/04/01-2025/03/31)
|
Japanese | 334.4 KB | |
2024-10-30 07:42 |
Inside Information Statement
臨時報告書
|
Japanese | 18.6 KB | |
2024-07-31 08:40 |
Inside Information Statement
臨時報告書
|
Japanese | 18.7 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
Ananda Pharma Plc | United Kingdom | N/A | ||
![]() |
AnGes, Inc. | Japan | 4563 |